|
gptkbp:instanceOf
|
lipoprotein
|
|
gptkbp:abbreviation
|
gptkb:Lp(a)
|
|
gptkbp:associatedWith
|
gptkb:cardiovascular_disease
atherosclerosis
|
|
gptkbp:category
|
gptkb:protein
lipoprotein
biomarker
|
|
gptkbp:clinicalTrialPhase
|
gptkb:Lipoprotein(a)_blood_test
|
|
gptkbp:compatibleWith
|
most mammals
|
|
gptkbp:component
|
blood plasma
|
|
gptkbp:contains
|
gptkb:apolipoprotein_B-100
gptkb:apolipoprotein(a)
cholesterol
phospholipids
triglycerides
|
|
gptkbp:discoveredBy
|
gptkb:Kåre_Berg
|
|
gptkbp:discoveredIn
|
1963
|
|
gptkbp:elevatedIn
|
genetic factors
|
|
gptkbp:elevatedLevel
|
>50 mg/dL
|
|
gptkbp:encodedBy
|
gptkb:LPA_gene
|
|
gptkbp:features
|
kringle IV repeats
|
|
gptkbp:halfLife
|
3-4 days
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lipoprotein(a)
|
|
gptkbp:loweredBy
|
gptkb:PCSK9_inhibitors
niacin
antisense oligonucleotides
|
|
gptkbp:measures
|
mg/dL
nmol/L
|
|
gptkbp:notSignificantlyAffectedBy
|
gptkb:food
exercise
statins
|
|
gptkbp:presentIn
|
humans
old world monkeys
|
|
gptkbp:range
|
<30 mg/dL (desirable)
|
|
gptkbp:riskFactor
|
stroke
coronary artery disease
peripheral artery disease
|
|
gptkbp:similarTo
|
gptkb:low-density_lipoprotein
|
|
gptkbp:bfsParent
|
gptkb:LPA
|
|
gptkbp:bfsLayer
|
5
|